Primary Thromboprophylaxis in Pancreatic Cancer Patients: Why Clinical Practice Guidelines Should Be Implemented

Cancers
Dominique FargeCorinne Frere

Abstract

Exocrine pancreatic ductal adenocarcinoma, simply referred to as pancreatic cancer (PC) has the worst prognosis of any malignancy. Despite recent advances in the use of adjuvant chemotherapy in PC, the prognosis remains poor, with fewer than 8% of patients being alive at 5 years after diagnosis. The prevalence of PC has steadily increased over the past decades, and it is projected to become the second-leading cause of cancer-related death by 2030. In this context, optimizing and integrating supportive care is important to improve quality of life and survival. Venous thromboembolism (VTE) is a common but preventable complication in PC patients. VTE occurs in one out of five PC patients and is associated with significantly reduced progression-free survival and overall survival. The appropriate use of primary thromboprophylaxis can drastically and safely reduce the rates of VTE in PC patients as shown from subgroup analysis of non-PC targeted placebo-controlled randomized trials of cancer patients and from two dedicated controlled randomized trials in locally advanced PC patients receiving chemotherapy. Therefore, primary thromboprophylaxis with a Grade 1B evidence level is recommended in locally advanced PC patients receiving che...Continue Reading

References

Aug 30, 1976·Zeitschrift Für Krebsforschung Und Klinische Onkologie. Cancer Research and Clinical Oncology·G J GasicS Niewiarowski
Jun 15, 1988·Thrombosis Research·P M SandsetM L Larsen
Aug 1, 1995·The British Journal of Surgery·A K KakkarR C Williamson
Jun 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H A BurrisD D Von Hoff
Aug 3, 2000·The Journal of Biological Chemistry·A E MastC L Hall
May 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ajay K KakkarRobin C N Williamson
Jun 9, 2004·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Vladimir Bobek, Josef Kovarík
Nov 4, 2004·The Lancet Oncology·Alok A Khorana, Robert L Fine
Feb 9, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Clara P W KlerkHarry R Büller
Dec 3, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J W BlomF R Rosendaal
Feb 8, 2006·Journal of Thrombosis and Haemostasis : JTH·J W BlomF R Rosendaal
Mar 1, 2006·Archives of Internal Medicine·Helen K ChewRichard H White
Feb 27, 2007·Journal of Thrombosis and Haemostasis : JTH·A A KhoranaG H Lyman
Jul 31, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M MandalàR Labianca
Jan 8, 2008·Gastroentérologie Clinique Et Biologique·Emmanuel MitryPhilippe Rougier
Apr 25, 2008·Journal of Thrombosis and Haemostasis : JTH·M DavilaJ L Francis
Sep 18, 2008·Journal of Thrombosis and Haemostasis : JTH·A A KhoranaM B Taubman
Aug 12, 2009·The Journal of Experimental Medicine·Grace M ThomasChristophe Dubois
Oct 29, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jeffrey I ZwickerBruce Furie
Aug 24, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Katherine E PorukSean J Mulvihill
Sep 3, 2010·Progress in Molecular Biology and Translational Science·Lubor Borsig
Sep 11, 2010·Blood·Cihan AyIngrid Pabinger
Apr 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Frederiek F van DoormaalHarry R Buller
May 13, 2011·The New England Journal of Medicine·Thierry ConroyUNKNOWN PRODIGE Intergroup
Jun 30, 2011·Thrombosis and Haemostasis·Laurel A MenapaceAlok A Khorana
Nov 22, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A MaraveyasG Bozas
Feb 18, 2012·The New England Journal of Medicine·Giancarlo AgnelliUNKNOWN SAVE-ONCO Investigators
Feb 13, 2013·European Journal of Clinical Investigation·Johannes ThalerIngrid Pabinger

❮ Previous
Next ❯

Software Mentioned

CASSINI
FRAGEM
SAVE
AVERT
ONCO
ONKOTEV
PROTECHT

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.